Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9

CAR-T cell therapy is effective for hematologic malignancies. However, considerable numbers of patients relapse after the treatment, partially due to poor expansion and limited persistence of CAR-T cells in vivo. Here, we demonstrate that human CAR-T cells polarized and expanded under a Th9-culture...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lintao, Bi, Enguang, Ma, Xingzhe, Xiong, Wei, Qian, Jianfei, Ye, Lingqun, Su, Pan, Wang, Qiang, Xiao, Liuling, Yang, Maojie, Lu, Yong, Yi, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677397/
https://www.ncbi.nlm.nih.gov/pubmed/33214555
http://dx.doi.org/10.1038/s41467-020-19672-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677397/
https://www.ncbi.nlm.nih.gov/pubmed/33214555
http://dx.doi.org/10.1038/s41467-020-19672-2

Ejemplares similares